Stanford Cancer Institute, Stanford University is a clinical research site located in Stanford, California, United States 94305.
Crixeo Clinical Trials Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.
Stanford Cancer Institute, Stanford University has participated in 3 clinical trials.
Therapeutic areas: Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma.
Sponsors: Celldex Therapeutics, Karyopharm Therapeutics Inc.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in California · View every site in Stanford
Trust Score: 84/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Stanford Cancer Institute, Stanford University has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Stanford Cancer Institute, Stanford University has 3 clinical trials on record. Their work covers Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma.
Stanford Cancer Institute, Stanford University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.